Myasthenia gravis: understanding treatment patterns and direct medical costs in the Czech Republic
Abstract Background Myasthenia gravis (MG) is a rare autoimmune disorder with significant clinical implications, including life-threatening myasthenic crises and exacerbations. Understanding real-world treatment patterns, especially associated direct medical costs, is essential for the effective man...
Κύριοι συγγραφείς: | Gleb Donin, Karla Mothejlová, Magda Horáková, Stanislav Vohanka |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
BMC
2024-12-01
|
Σειρά: | Orphanet Journal of Rare Diseases |
Θέματα: | |
Διαθέσιμο Online: | https://doi.org/10.1186/s13023-024-03504-3 |
Παρόμοια τεκμήρια
-
Burden of Myasthenia Gravis in the Czech Republic: Analysis of the Nationwide Patient Registry
ανά: Stanislav Voháňka, κ.ά.
Έκδοση: (2024-12-01) -
IMMUNOPATHOGENESIS OF MYASTHENIA GRAVIS (REVIEW)
ανά: E. D. Gasymly
Έκδοση: (2018-06-01) -
Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
ανά: Courtney Townsel, κ.ά.
Έκδοση: (2016-03-01) -
Pregnancy with Myasthenia Gravis
ανά: Ninuk Dwi ariningtyas, κ.ά.
Έκδοση: (2020-01-01) -
Delayed diagnosis of distal myasthenia gravis: a case report
ανά: M. L. Cao, κ.ά.
Έκδοση: (2024-11-01)